Breast cancer metastasis: Is it a matter of OMICS and proper ex-vivo models?-Reference-Cited by-同舟云学术

Breast cancer metastasis: Is it a matter of OMICS and proper ex-vivo models?

Published:2022 Issue: Volume:20 Page:4003-4008
ISSN:2001-0370
Container-title:Computational and Structural Biotechnology Journal
language:en
Short-container-title:Computational and Structural Biotechnology Journal

Author:

Cioce Mario,Sacconi Andrea,Donzelli Sara,Bonomo Claudia,Perracchio Letizia,Carosi Mariantonia,Telera Stefano,Fazio Vito Michele,Botti Claudio,Strano Sabrina,Blandino Giovanni

Publisher

Elsevier BV

Subject

Computer Science Applications,Genetics,Biochemistry,Structural Biology,Biophysics,Biotechnology

Reference59 articles.

1. Incidence and time trends of brain metastases admissions among breast cancer patients in Sweden;Frisk;Br J Cancer,2012

2. Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis;Pelletier;Breast Cancer Res Treat,2008

3. Breast cancer subtypes predict the preferential site of distant metastases: a SEER based study;Wu;Oncotarget,2017

4. Comprehensive molecular portraits of invasive lobular breast cancer;Ciriello;Cell,2015

5. Genomic and transcriptomic analyses of breast cancer primaries and matched metastases in AURORA, the Breast International Group (BIG) molecular screening initiative;Aftimos;Cancer Discov,2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Organ-Specificity of Breast Cancer Metastasis;International Journal of Molecular Sciences;2023-10-26

2. The new world of RNA diagnostics and therapeutics;Journal of Experimental & Clinical Cancer Research;2023-07-29

3. Interrogating colorectal cancer metastasis to liver: a search for clinically viable compounds and mechanistic insights in colorectal cancer Patient Derived Organoids;Journal of Experimental & Clinical Cancer Research;2023-07-17

4. Harnessing the value of TCTP in breast cancer treatment resistance: an opportunity for personalized therapy;Cancer Drug Resistance;2023-07-13